Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Claudius H. Conrad

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9912-4545; OpenAlex author ID A5063972129. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 10

  1. Recalibrating "Unresectable" in Pancreatic Cancer. Last author DOI 10.1001/jamasurg.2026.2998↗
  2. Extravascular coagulation stabilizes pro-fibrotic stromal states via tumor-intrinsic PAR1 signaling in pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.06.25.734662↗
  3. The impact of the COVID-19 pandemic on patients with pancreatic cancer. Last author DOI 10.1016/j.gassur.2024.03.008↗
  4. R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Last author DOI 10.1016/j.suronc.2023.101961↗
  5. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? Last author DOI 10.1007/s11605-022-05336-7↗
  6. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. Last author DOI 10.1016/j.suronc.2021.101694↗
  7. ASO AUTHOR REFLECTIONS: Laparoscopic Distal Pancreatectomy for Pancreatic Cancer: Good, Bad, or Even Ugly? Last author DOI 10.1245/s10434-021-10332-3↗
  8. Preoperative Chemotherapy for Pancreatic Cancer Improves Survival and R0 Rate Even in Early Stage I. Last author DOI 10.1007/s11605-020-04601-x↗
  9. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-014-4285-2↗
  10. Surgical palliation of pancreatic cancer. Co-author DOI 10.1097/ppo.0b013e3182797dfe↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eduardo A. Vega · 6 shared papers, 2020–2024 · strength 1.02
  2. Omid Salehi · 5 shared papers, 2020–2024 · strength 0.84
  3. Onur Cagri Kutlu · 5 shared papers, 2020–2023 · strength 0.79
  4. Kathryn Chen Tsai · 1 shared paper, 2026 · strength 0.50
  5. Oscar Salirrosas · 2 shared papers, 2023–2024 · strength 0.41
  6. Sebastián Mellado · 2 shared papers, 2022–2023 · strength 0.33
  7. Melissa L. Fishel · 1 shared paper, 2026 · strength 0.25
  8. Hye‐ran Moon · 1 shared paper, 2026 · strength 0.25
  9. Bumsoo Han · 1 shared paper, 2026 · strength 0.25
  10. Sae Rome Choi · 1 shared paper, 2026 · strength 0.25
  11. Matthew J. Flick · 1 shared paper, 2026 · strength 0.25
  12. Ariana M. Chirban · 1 shared paper, 2023 · strength 0.18
  13. David J. Lee · 1 shared paper, 2022 · strength 0.15
  14. Keith D. Lillemoe · 1 shared paper, 2012 · strength 0.06
  15. An Ngo‐Huang · 1 shared paper, 2015 · strength 0.04
  16. Nathan H. Parker · 1 shared paper, 2015 · strength 0.04
  17. Matthew H. G. Katz · 1 shared paper, 2015 · strength 0.04
  18. Aparna Balachandran · 1 shared paper, 2015 · strength 0.04
  19. Maria Q. B. Petzel · 1 shared paper, 2015 · strength 0.04
  20. Amanda Beth Cooper · 1 shared paper, 2015 · strength 0.04
  21. Douglas B. Evans · 1 shared paper, 2015 · strength 0.04
  22. Jean‐Nicolas Vauthey · 1 shared paper, 2015 · strength 0.04
  23. Jason B. Fleming · 1 shared paper, 2015 · strength 0.04
  24. Gauri Rajani Varadhachary · 1 shared paper, 2015 · strength 0.04
  25. David R. Fogelman · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.